rs1085307324
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1_SupportingPS4PS3PP3PM2_Supporting
This summary comes from the ClinGen Evidence Repository: BMPR2 c.1258T>C is a missense variant predicted to cause substitution of cysteine to arginine at amino acid position 420 (p.Cys420Arg). This variant resides within the catalytic kinase domain but is not a known critical residue (PM1_moderate met). The variant is absent in gnomAD databases, meeting PM2_supporting criterion (BA1 and BS1 not met). The REVEL score of 0.934 meets PP3_suporting criteria (>=0.75) (BP4 not met). Functional studies indicated subcellular mislocalization of the mutant protein (PMID:25688877) and decreased receptor-mediated signaling (PMID:12045205) (PS3 met). At least five unrelated probands have been reported in the literature (PMID:11115378, 21801371, 27587546, 32634488, 32966279), meeting the PS4 threshold of >4 probands. Alternative missense variants have been reported in the same location but these variants are pending expert panel curation and PM5 is not scored at this time. In summary, this variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS4_strong, PS3_strong, PM1_ moderate, PM2_supporting, PP3 (VCEP specification version 1.1.0, 1/18/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA350341977/MONDO:0015924/125
Frequency
Consequence
NM_001204.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMPR2 | ENST00000374580.10 | c.1258T>C | p.Cys420Arg | missense_variant | Exon 9 of 13 | 1 | NM_001204.7 | ENSP00000363708.4 | ||
BMPR2 | ENST00000374574.2 | c.1258T>C | p.Cys420Arg | missense_variant | Exon 9 of 12 | 2 | ENSP00000363702.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension Pathogenic:1
BMPR2 c.1258T>C is a missense variant predicted to cause substitution of cysteine to arginine at amino acid position 420 (p.Cys420Arg). This variant resides within the catalytic kinase domain but is not a known critical residue (PM1_moderate met). The variant is absent in gnomAD databases, meeting PM2_supporting criterion (BA1 and BS1 not met). The REVEL score of 0.934 meets PP3_suporting criteria (>=0.75) (BP4 not met). Functional studies indicated subcellular mislocalization of the mutant protein (PMID: 25688877) and decreased receptor-mediated signaling (PMID: 12045205) (PS3 met). At least five unrelated probands have been reported in the literature (PMID: 11115378, 21801371, 27587546, 32634488, 32966279), meeting the PS4 threshold of >4 probands. Alternative missense variants have been reported in the same location but these variants are pending expert panel curation and PM5 is not scored at this time. In summary, this variant meets the criteria to be classified as pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PS4_strong, PS3_strong, PM1_ moderate, PM2_supporting, PP3 (VCEP specification version 1.1.0, 1/18/2024). -
Pulmonary hypertension, primary, 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at